000739SZSE

Draft of the Second Employee Stock Ownership Plan of Pro Pharmaceutical Co., Ltd.

Apeloa Pharmaceutical Co., Ltd.··32 pages

✨ AI Summary

Pro Pharmaceutical Co., Ltd. has proposed a second employee stock ownership plan, subject to shareholder approval. The plan aims to enhance employee engagement and align interests with shareholders. It involves a maximum of 3.83 million shares, with a purchase price set at 8.92 RMB per share. The plan will be managed by a dedicated committee and includes performance-based vesting conditions over a five-year period.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Draft of the Second Employee Stock Ownership Plan of Pro Pharmaceutical Co., Ltd.

Securities Abbreviation: Pro Pharmaceutical
Securities Code: 000739
Date: March 2026

Declaration

The company and all members of the board guarantee that the content of this employee stock ownership plan is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Risk Warning

  1. This employee stock ownership plan must be approved by the company's shareholders' meeting before implementation, and there is uncertainty regarding whether such approval will be obtained.
  2. The funding sources, contribution ratios, and implementation plans related to this employee stock ownership plan are preliminary proposals, and there is uncertainty regarding the completion of the plan.
  3. Employees participating in this plan must comply with legal regulations, participate voluntarily, and bear their own risks. If the subscription amount is low, there is a risk that the plan may not reach the expected scale.
  4. The company will disclose relevant progress according to regulations, and investors are advised to make cautious decisions and pay attention to investment risks.

Special Reminder

The terms used in this section are consistent with those in the "Definitions" section.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.